Technetium Tc 99m Medronate
(IUPNVOAUFBLQME-LDYDCSBASA-J)
Structure
- SMILES
- [O-]P(=O)(CP(=O)([O-])[O-])[O-].O.O.[98Tc+4]
- Type(s)
- Approved
- ATC code(s)
- V09BA02
- Molecular Formula:
- CH6O8P2Tc
- Molecular Weight:
- 305.908
- Log P:
- 0.9210
- Hydrogen Bond Acceptor:
- 8
- Hydrogen Bond Donor:
- 2
- TPSA:
- 164.46
- CAS Number(s):
- 121524-79-6
Synonym(s)
1.
Technetium Tc 99m Medronate
2.
Tc-99m MDP
3.
Technetium Methylene Diphosphonate
4.
99mTc-MDP
5.
99mTc-Methylene Diphosphonate
6.
Tc-99 Medronate
7.
Tc-99m Methylene Diphosphonate
8.
Technetium Tc 99m Methylenediphosphonate
9.
99mTc Methylene Diphosphonate
10.
Diphosphonate, 99mTc-Methylene
11.
Diphosphonate, Tc-99m Methylene
12.
Diphosphonate, Technetium Methylene
13.
Medronate, Tc-99
14.
Methylene Diphosphonate, Tc-99m
15.
Methylene Diphosphonate, Technetium
16.
Tc 99 Medronate
17.
Tc 99m Methylene Diphosphonate
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Unevaluable event | FAERS: 2 | US FAERS | |
| 2 | Chest discomfort | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 3 | Flushing | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 4 | Hypotension | FAERS: 1 | US FAERS | |
| 5 | Injection site erythema | FAERS: 1 | US FAERS | |
| 6 | Injection site mass | FAERS: 1 | US FAERS | |
| 7 | Injection site pruritus | FAERS: 1 | US FAERS | |
| 8 | Abdominal Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 9 | Anaphylactoid Reaction | Canada Vigilance: 1 | Canada Vigilance | |
| 10 | Arthralgia | Canada Vigilance: 1 | Canada Vigilance | |
| 11 | Asthenia | Canada Vigilance: 1 | Canada Vigilance | |
| 12 | Back Pain | Canada Vigilance: 3 | Canada Vigilance | |
| 13 | Burning sensation | Canada Vigilance: 1 | Canada Vigilance | |
| 14 | Chest Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 15 | Chills | Canada Vigilance: 1 | Canada Vigilance | |
| 16 | Cold sweat | Canada Vigilance: 1 | Canada Vigilance | |
| 17 | Dizziness | Canada Vigilance: 2 | Canada Vigilance | |
| 18 | Erythema | Canada Vigilance: 4 | Canada Vigilance | |
| 19 | Feeling Cold | Canada Vigilance: 1 | Canada Vigilance | |
| 20 | Headache | Canada Vigilance: 9 | Canada Vigilance | |
| 21 | Hypersensitivity | Canada Vigilance: 1 | Canada Vigilance | |
| 22 | Hypoxia | Canada Vigilance: 1 | Canada Vigilance | |
| 23 | Injection Site Reaction | Canada Vigilance: 1 | Canada Vigilance | |
| 24 | Malaise | Canada Vigilance: 2 | Canada Vigilance | |
| 25 | Musculoskeletal Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 26 | Nausea | Canada Vigilance: 13 | Canada Vigilance | |
| 27 | Neck Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 28 | Nonspecific reaction | Canada Vigilance: 1 | Canada Vigilance | |
| 29 | Pain | Canada Vigilance: 2 | Canada Vigilance | |
| 30 | Presyncope | Canada Vigilance: 1 | Canada Vigilance | |
| 31 | Pruritus | Canada Vigilance: 6 | Canada Vigilance | |
| 32 | Rash erythematous | Canada Vigilance: 1 | Canada Vigilance | |
| 33 | Swelling | Canada Vigilance: 1 | Canada Vigilance | |
| 34 | Syncope | Canada Vigilance: 1 | Canada Vigilance | |
| 35 | Tachycardia | Canada Vigilance: 1 | Canada Vigilance | |
| 36 | Toothache | Canada Vigilance: 1 | Canada Vigilance | |
| 37 | Urticaria | Canada Vigilance: 3 | Canada Vigilance | |
| 38 | Vitreous floaters | Canada Vigilance: 1 | Canada Vigilance | |
| 39 | Vomiting | Canada Vigilance: 3 | Canada Vigilance | |
| 40 | Wheezing | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.